cancer
Lipids: The New Target For Cancer Immunotherapy
Lipids, rather than proteins, expressed by leukemia cells are a promising new target for T cell-driven cancer immunotherapy.
Blocking STAT5 To Fight Leukemia
Blocking STAT5 in conjunction with standard tyrosine kinase inhibitor drugs could be a powerful one-two punch that kills leukemic cells.
Insights Into Cancer Resistance From The Blind Mole Rat
The blind mole rat may not be able to see, but its genome could shed light on why it does not develop cancer.
Novel Uric Acid Antioxidant Pathway Could Fight Cancer
Though uric acid crystals may be the bane of gout patients, scientists have shown that intracellular uric acid plays an important antioxidant role.
Astellas’ Prostate Cancer Drug Available In Japan
The androgen receptor signaling inhibitor XTANDI® has been approved for castration-resistant prostate cancer in Japan.
PTENα: An Exception To The Rule
PTENα, an alternative form of the tumor suppressor PTEN, uses a previously unknown start codon rather than the typical AUG.
Six Gene Loci Linked To Colorectal Cancer In East Asians
A large genome-wide association study (GWAS) in the East Asian population has identified six genetic loci linked to higher risk of colorectal cancer.
HSA Approves Lung Cancer Drug Giotrif®
Singaporean non-small cell lung cancer patients with EGFR mutations can look forward to new treatment possibilities with Boehringer Ingelheim's Giotrif®.
Novartis Launches Blood Cancer Drug, Jakavi®
Jakavi, the only approved oral medication for the blood cancer myelofibrosis, has been introduced in Singapore and 50 other countries.
